Patents by Inventor Chun-Tang Chiou

Chun-Tang Chiou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230122849
    Abstract: The present invention relates to a method of treating moderate or severe symptoms of COVID-19 using a plant composition. The plant composition comprises Prepared Monkshood Daughter Root (Aconitum carmichaelii), Fragrant Solomonseal Rhizome (Polygonatum odoratum), Indian Bread (Poria cocos), Pinellia tuber (Pinellia ternata), Oriental Wormwood Herb (Artemisia scoparia), Scutellaria Root (Scutellaria baicalensis), Mongolian Snakegourd Fruit (Trichosanthes kirilowii), Magnolia Bark (Magnolia officinalis), Heartleaf Houttuynia Herb (Houttuynia cordata), and Baked Licorice Root and Rhizome (Glycyrrhiza glabra), which is used as a traditional Chinese medicine composition.
    Type: Application
    Filed: October 19, 2022
    Publication date: April 20, 2023
    Inventors: YI-CHANG SU, WEN-HUI CHIOU, YUH-CHIANG SHEN, WEN-CHI WEI, KENG-CHANG TSAI, CHIA-CHING LIAO, YU-HWEI TSENG, CHUN-TANG CHIOU, YU-CHI LIN, LI-HSIANG WANG, CHIEN-HSIEN HUANG, CHIA-MO LIN, CHI-KUEI LIN, YI-CHIA HUANG, CHIEN-JUNG LIN, JUI-SHAN LIN, YA-SUNG YANG, CHUN-HSIANG CHIU, SHUN-PING CHENG, HSIEN-HWA KUO, WU-PU LIN, CHEN-SHIEN LIN, BO-CHENG LAI, YUAN-NIAN HSU, TSUNG-LUNG TSAI, WEI-CHEN HSU, TIENG-SIONG FONG, YI-WEN HUANG, CHIA-I TSAI, YA-CHEN YANG, MING-CHE TSAI, MING-HUEI CHENG, SHIH-WEI HUANG
  • Publication number: 20230124965
    Abstract: The present invention relates to a plant composition, a traditional Chinese medicine composition and use thereof. The plant composition comprises Prepared Monkshood Daughter Root (Aconitum carmichaelii), Fragrant Solomonseal Rhizome (Polygonatum odoratum), Indian Bread (Poria cocos), Pinellia tuber (Pinellia ternata), Oriental Wormwood Herb (Artemisia scoparia), Scutellaria Root (Scutellaria baicalensis), Mongolian Snakegourd Fruit (Trichosanthes kirilowii), Magnolia Bark (Magnolia officinalis), Heartleaf Houttuynia Herb (Houttuynia cordata) and Baked Licorice Root and Rhizome (Glycyrrhiza glabra), which is used as a traditional Chinese medicine composition. In addition, the traditional Chinese medicine composition can be used to treat pulmonary embolism or pulmonary fibrosis.
    Type: Application
    Filed: October 19, 2022
    Publication date: April 20, 2023
    Inventors: YI-CHANG SU, WEN-HUI CHIOU, YUH-CHIANG SHEN, WEN-CHI WEI, KENG-CHANG TSAI, CHIA-CHING LIAO, YU-HWEI TSENG, CHUN-TANG CHIOU, YU-CHI LIN, LI-HSIANG WANG
  • Patent number: 11331362
    Abstract: A composition of plant ingredients, a herbal composition for inhibiting coronavirus and cytokine storm, and a preparation method of the herbal composition are introduced. The composition of plant ingredients has Heartleaf Houttuynia, Indigowoad Root, Fineleaf Nepeta, Saposhnikovia Root, Mulberry Leaf, Scutellaria Root, Mongolian Snakegourd Fruit, Magnolia Bark, Peppermint Herb and Baked Liquorice Root. The herbal composition has 1 to 20 parts by weight of Heartleaf Houttuynia, Indigowoad Root, Fineleaf Nepeta, Saposhnikovia Root, Mulberry Leaf, Scutellaria Root, Mongolian Snakegourd Fruit, Magnolia Bark, Peppermint Herb and Baked Liquorice Root.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: May 17, 2022
    Assignee: NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE
    Inventors: Yi-Chang Su, Wen-Hui Chiou, Yao-Haur Kuo, Keng-Chang Tsai, Chia-Ching Liao, Wen-Chi Wei, Chun-Tang Chiou, Kuo-Ming Yeh, Yi-Chia Huang, Chien-Jung Lin, Jui-Shan Lin
  • Publication number: 20210353703
    Abstract: A composition of plant ingredients, a herbal composition for inhibiting coronavirus and cytokine storm, and a preparation method of the herbal composition are introduced. The composition of plant ingredients has Heartleaf Houttuynia, Indigowoad Root, Fineleaf Nepeta, Saposhnikovia Root, Mulberry Leaf, Scutellaria Root, Mongolian Snakegourd Fruit, Magnolia Bark, Peppermint Herb and Baked Liquorice Root. The herbal composition has 1 to 20 parts by weight of Heartleaf Houttuynia, Indigowoad Root, Fineleaf Nepeta, Saposhnikovia Root, Mulberry Leaf, Scutellaria Root, Mongolian Snakegourd Fruit, Magnolia Bark, Peppermint Herb and Baked Liquorice Root.
    Type: Application
    Filed: December 21, 2020
    Publication date: November 18, 2021
    Inventors: YI-CHANG SU, WEN-HUI CHIOU, YAO-HAUR KUO, KENG-CHANG TSAI, CHIA-CHING LIAO, WEN-CHI WEI, CHUN-TANG CHIOU, KUO-MING YEH, YI-CHIA HUANG, CHIEN-JUNG LIN, JUI-SHAN LIN
  • Patent number: 8173693
    Abstract: The present invention is related to derivatives of benzenesulfonamide represented by formula (I), and the pharmaceutical composition thereof. In addition, the benzenesulfonamide derivatives disclosed in the present invention can serve as potential cell cycle inhibitors, and thereby these benzenesulfonamide derivatives and the pharmaceutical composition thereof can be antitumor drug candidates, which might aim at cell cycle. Particularly, the benzenesulfonamide derivatives disclosed in the present invention may function as antitumor drugs to treat solid cancers.
    Type: Grant
    Filed: February 23, 2011
    Date of Patent: May 8, 2012
    Assignee: Purzer Pharmaceutical Co., Ltd.
    Inventors: Ji-Wang Chern, Grace Shiahuy Chen, Pei-Teh Chang, Kuan-Yu Chen, Meng-Ling Chen, Hsueh-Yun Lee, Chiung Hua Huang, Chun-Tang Chiou
  • Publication number: 20110230651
    Abstract: The present invention is related to derivatives of benzenesulfonamide represented by formula (I), and the pharmaceutical composition thereof. In addition, the benzenesulfonamide derivatives disclosed in the present invention can serve as potential cell cycle inhibitors, and thereby these benzenesulfonamide derivatives and the pharmaceutical composition thereof can be antitumor drug candidates, which might aim at cell cycle. Particularly, the benzenesulfonamide derivatives disclosed in the present invention may function as antitumor drugs to treat solid cancers.
    Type: Application
    Filed: February 23, 2011
    Publication date: September 22, 2011
    Applicant: Purzer Pharmaceutical Co., LTD.
    Inventors: Ji-Wang Chern, Grace Shiahuy Chen, Pei-Teh Chang, Kuan-Yu Chen, Meng-Ling Chen, Hsueh-Yun Lee, Chiung Hua Huang, Chun-Tang Chiou